Rumors of competitive products getting approved cause disturbance, company's stock price 'plunges in response'? Jiudian Pharmaceuticals responds

Golden Ten data, January 16 news, on January 15, Jiudian Pharmaceutical big dump 9.86%. As of the midday closing today, the stock fell 1.34%, with a total Market Cap of about 7.7 billion yuan. On the news front, on January 15, a screenshot of a suspected Luoxuofen Sodium Gel Patch from Le Ming Pharmaceutical circulated in the market. In response, a person related to the company as an investor called Jiudian Pharmaceutical, and responded that the company learned of the relevant market rumors yesterday, immediately verified through official channels and third-party professional data platforms, did not obtain relevant information, and could not confirm the authenticity of the rumors. Regarding whether the approval of competing products will affect the company, the person said that if new competitors enter, it will definitely have a certain impact on the company. However, as Luoxuofen Sodium Gel Patch is a generic drug, it has attracted dozens of companies to apply for approval in the past two years, so it is normal for products to be approved.